rss
Evid Based Med 2007;12:172 doi:10.1136/ebm.12.6.172
  • Therapeutics

Warfarin reduced major stroke more than aspirin in elderly patients with atrial fibrillation in primary care.

In elderly patients with atrial fibrillation (AF) in primary care, is warfarin more effective than aspirin for preventing major stroke, arterial embolism, and intracranial haemorrhage?

Mant J, Hobbs FDR, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493–503.

Clinical impact ratings GP/FP/Primary care ★★★★★★⋆ Geriatrics ★★★★★★⋆ Cardiology ★★★★★★⋆ Haematology ★★★★★★⋆ Neurology ★★★★★★⋆

METHODS

GraphicDesign:

randomised controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged [BAFTA] study).

GraphicAllocation:

concealed.*

GraphicBlinding:

blinded (outcome assessors).*

GraphicFollow-up period:

mean 2.7 years.

GraphicSetting:

234 general practices in England and Wales.

GraphicPatients:

973 patients ≥75 years of age (mean age 81y, 55% men) with AF or flutter within the past 2 years (confirmed by electrocardiography). Exclusion criteria included terminal illness, rheumatic heart disease, major …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.